Results 21 to 30 of about 306,632 (271)

Multidrug-resistant tuberculosis [PDF]

BMC Infectious Diseases, 2008
With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of countries. However, the emergence of mutated strains of Mycobacterium tuberculosis that are resistant to the major anti-
McNerney Ruth, Zager Ellen M
openaire   +4 more sources

Microscopic-observation drug-susceptibility assay for the diagnosis of TB. [PDF]

, 2006
BACKGROUND: New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in ...
Caviedes, Luz, Coronel, Jorge, Escombe, A Roderick, Evans, Carlton AW, Friedland, Jon S, Gilman, Robert H, Hollm-Delgado, Maria-Graciela, LaChira, Doris, Moore, David AJ, Oberhelman, Richard, Piñedo, Yvette, Salazar, Cayo, Sanchez, Eduardo, Saravia, Juan Carlos, Vivar, Aldo   +14 more
core   +1 more source

Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014

Antimicrobial Resistance and Infection Control, 2018
Background By using whole genome sequence data we aimed at describing a population snapshot of carbapenemase-producing K. pneumoniae isolated from hospitalized patients in Germany between 2008 and 2014.
Laura Becker, Martin Kaase, Yvonne Pfeifer, Stephan Fuchs, Annicka Reuss, Anja von Laer, Muna Abu Sin, Miriam Korte-Berwanger, Sören Gatermann, Guido Werner   +9 more
doaj   +1 more source

Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis [PDF]

, 2012
BACKGROUND: Paediatric multidrug-resistant (MDR) tuberculosis is a public health challenge of growing concern, accounting for an estimated 15% of all global cases of MDR tuberculosis. Clinical management is especially challenging, and recommendations are
Abubakar, Al-Dabbagh, Borenstien, Caminero, Dena Ettehad, Drobac, du Cros, Fairlie, Falzon, Feja, Furin, Furin, Golder, Graham S Cooke, Granich, Guyatt, H Simon Schaaf, Hesseling, Hesseling, Houwert, James A Seddon, Johnston, Laserson, Leung, Mendez Echevarria, Mitnick, Munsiff, Nathan Ford, Nelson, Newcombe, Nicol, Orenstein, Padayatchi, Riley, Rucker, Schaaf, Schaaf, Schaaf, Schaaf, Schaaf, Seddon, Smith, Swanson   +42 more
core   +2 more sources

Multidrug-Resistant Tuberculosis

Chest, 2006
Multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis resistant to both isoniazid and rifampicin with or without resistance to other drugs is among the most worrisome elements of the pandemic of antibiotic resistance. Globally, about three per cent of all newly diagnosed patients have MDR-TB.
S K, Sharma, A, Mohan
openaire   +2 more sources

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019

Antimicrobial Resistance and Infection Control, 2022
Background Since May 2016, infection and colonisation with carbapenem non-susceptible Acinetobacter spp. (CRA) and Enterobacterales (CRE) have to be notified to health authorities in Germany. The aim of our study was to assess the epidemiology of CRA and
Anja von Laer, Tim Eckmanns, Benedikt Zacher, Niels Pfennigwerth, Sören G. Gatermann, Felix Reichert, Michaela Diercke, Gyde Steffen, Doris Altmann, Annicka Reuss   +9 more
doaj   +1 more source

Randomized controlled trial to determine the impact of probiotic administration on colonization with multidrug-resistant organisms in critically ill patients [PDF]

, 2015
This was a randomized controlled pilot study of Lactobacillus rhamnosus GG versus standard of care to prevent gastrointestinal multidrug-resistant organism (MDRO) colonization in ICU patients. Seventy subjects were included in analyses.
Babcock, Hilary M, Bommarito, Kerry M, Burnham, Carey-Ann D, Dubberke, Erik R, Fraser, Victoria J, Hink, Tiffany, Kollef, Marin H, Kwon, Jennie H, Reske, Kimberly A, Seiler, Sondra M   +9 more
core   +2 more sources

The Birth and Demise of the ISApl1-mcr-1-ISApl1 Composite Transposon: the Vehicle for Transferable Colistin Resistance

mBio, 2018
The origin and mobilization of the ~2,609-bp DNA segment containing the mobile colistin resistance gene mcr-1 continue to be sources of uncertainty, but recent evidence suggests that the gene originated in Moraxella species.
Erik Snesrud, Patrick McGann, Michael Chandler   +2 more
doaj   +1 more source

When good bugs go bad: Epidemiology and antimicrobial resistance profiles of Corynebacterium striatum, an emerging multidrug-resistant, opportunistic pathogen [PDF]

, 2017
Infections with Corynebacterium striatum have been described in the literature over the last 2 decades, with the majority being bacteremia, central line infections, and occasionally, endocarditis.
Anderson, Neil, Burnham, Carey-Ann D, McMullen, Allison R, Shupe, Angela, Wallace, Meghan A   +4 more
core   +2 more sources

Multidrug-resistant Tuberculosis

Medical Clinics of North America, 2013
Multidrug-resistant tuberculosis (MDR-TB) threatens to become the dominant form of tuberculosis in many parts of the world because of decades of inappropriate treatment on a global scale. Infection with MDR-TB is associated with poor outcomes because of delays in treatment and the need for complex, toxic, and long medication regimens.
Lemos, Antônio Carlos Moreira, Matos, Eliana Dias   +1 more
openaire   +9 more sources